Amrutanjan Health Care Limited has officially commissioned its new sanitary napkin manufacturing facility in Seetharampur Village, Shabad Mandal, Rangareddy District, Telangana. The greenfield project, located approximately 45 km from Hyderabad, represents a ₹150 crore investment aimed at scaling the company’s feminine hygiene operations under its Comfy brand. This development marks the company’s fifth manufacturing plant and is designed to leverage Hyderabad’s industrial ecosystem and connectivity to key markets across India.

The commissioning was disclosed to stock exchanges on August 5, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing confirms that the facility is now operational, transitioning from an investment phase to active production. This move strengthens Amrutanjan’s domestic manufacturing footprint and aligns with the "Make in India" initiative by establishing future-ready production capabilities in a strategic location.

Facility Specifications and Capacity

The new plant is spread across 10 acres with a built-up area of 1.4 lakh sq. ft. It features two fully automated high-speed production lines imported from Japan, positioning it among India’s fastest sanitary napkin manufacturing facilities. The design allows for capacity expansion based on market demand.

Employment and Sustainability Impact

The facility is expected to generate significant local economic value by creating 200 direct and 150 indirect employment opportunities. This supports the regional workforce while strengthening the local manufacturing ecosystem in rural Telangana.

Sustainability features are integrated into the plant’s infrastructure, including rainwater harvesting, an on-site Sewage Treatment Plant (STP), waste recycling systems, and energy-efficient LED lighting. The company has also indicated plans to incorporate solar power in the future, reinforcing its commitment to responsible manufacturing practices.

Strategic Implications

With an annual production capacity of 700 million napkins, this facility significantly boosts Amrutanjan Health Care’s output capabilities. The strategic location near Hyderabad provides efficient access to raw materials and distribution networks, potentially reducing logistics costs and improving time-to-market for its Comfy brand products. As the company’s fifth plant, this expansion underscores a clear strategy to consolidate its leadership in the consumer healthcare sector through scaled, automated, and sustainable manufacturing.

Amrutanjan Health Care Limited has paid lease rent arrears of ₹9,74,67,151 to Kapaleeswarar Temple, complying with an order from the Madras High Court. The payment was executed on August 1, 2026, subject to Tax Deduction at Source, resolving a long-standing legal dispute regarding the validity of lease charges under state endowment laws. The company stated that the settlement does not significantly impact its business or operations.

The disclosure was made under Regulation 30 read with Clause 20 of Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The payment fulfills the directive issued by the Hon'ble Madras High Court in Writ Petition No. 35484 of 2005 and its related appeal. The court had previously dismissed the company's challenge to the proviso to Section 34A(5) of the Tamil Nadu Hindu Religious and Charitable Endowment Act 1959, ruling it neither illegal nor ultra vires.

The Madras High Court order, dated March 17, 2026, mandated the payment by August 2, 2026. Amrutanjan Health Care Limited completed the transaction ahead of this deadline. The legal proceedings centered on the company's attempt to declare the specific section of the endowment act unenforceable as it applied to the firm's lease arrangements.

Legal and Financial Details

The following details outline the regulatory compliance and financial specifics of the settlement:

The company cited SEBI Circular no. SEBI/HO/CFD/CFD-PoD-I/P/CIR/2023/123 dated July 13, 2023, for the structured disclosure of these details. The dismissal of the writ petition confirmed the enforceability of the lease rent provisions under the state act.

What the Numbers Show

The settlement of ₹9.74 crore represents a one-time cash outflow to resolve a legacy legal liability. By executing the payment before the August 2 deadline, the company avoided potential enforcement actions or penalties associated with non-compliance. The management's assertion that there is "no significant impact" suggests the amount is manageable within the company's current liquidity position, allowing operations to continue without disruption while closing this chapter of litigation.